Ha seleccionado la visión en Inglés
Descriptor en español: |
Levamisol
| ||||||
Descriptor en inglés: | Levamisole | ||||||
Descriptor en portugués: | Levamisol | ||||||
Descriptor en francés: | Lévamisole | ||||||
Término(s) alternativo(s): |
Decaris Dekaris Hydrochloride, Levamisole L-Tetramisole Levamisole Hydrochloride Levotetramisole Solaskil |
||||||
Código(s) jeráquico(s): |
D02.886.675.346 D03.383.129.308.480 D03.383.129.708.346 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D007978 | ||||||
Nota de alcance: | An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) |
||||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Acción Farmacológica: |
Adyuvantes Inmunológicos Antinematodos Antirreumáticos |
||||||
Número de registro: | 2880D3468G | ||||||
Nombre CAS Tipo 1: | Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)- | ||||||
Nota Pública de MeSH: | 74 |
||||||
Nota de historia: | 74 |
||||||
Identificador de DeCS: | 28126 | ||||||
ID del Descriptor: | D007978 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1974 | ||||||
Fecha de entrada: | 01/01/1999 | ||||||
Fecha de revisión: | 31/05/2016 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Levamisole
- Concepto preferido
Levamisole Hydrochloride
- Más estrecho
Solaskil
- Más estrecho
Dekaris
- Más estrecho
UI del concepto |
M0012431 |
Nota de alcance | An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) |
Término preferido | Levamisole |
Término(s) alternativo(s) |
L-Tetramisole Levotetramisole |
UI del concepto |
M0330203 |
Término preferido | Levamisole Hydrochloride |
Término(s) alternativo(s) |
Hydrochloride, Levamisole |
UI del concepto |
M0353243 |
Término preferido | Solaskil |
UI del concepto |
M0012432 |
Término preferido | Dekaris |
Término(s) alternativo(s) |
Decaris |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta